Almonertinib-induced interstitial lung disease in a lung adenocarcinoma patient complicated with interstitial lung abnormality

Qian Zhou, Zhong Hu, Xin Li, Xiaokui Tang

Open source

DOI
10.1186/s12890-023-02367-x
Published
2023-03-08
Container
BMC Pulmonary Medicine
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12890-023-02367-x,
  title = {Almonertinib-induced interstitial lung disease in a lung adenocarcinoma patient complicated with interstitial lung abnormality},
  author = {Qian Zhou and Zhong Hu and Xin Li and Xiaokui Tang},
  year = {2023},
  journal = {BMC Pulmonary Medicine},
  doi = {10.1186/s12890-023-02367-x},
  url = {https://doi.org/10.1186/s12890-023-02367-x}
}

RIS

TY  - JOUR
TI  - Almonertinib-induced interstitial lung disease in a lung adenocarcinoma patient complicated with interstitial lung abnormality
AU  - Qian Zhou
AU  - Zhong Hu
AU  - Xin Li
AU  - Xiaokui Tang
PY  - 2023
JO  - BMC Pulmonary Medicine
DO  - 10.1186/s12890-023-02367-x
UR  - https://doi.org/10.1186/s12890-023-02367-x
ER  - 

APA

Zhou, Q., Hu, Z., Li, X., & Tang, X. (2023). Almonertinib-induced interstitial lung disease in a lung adenocarcinoma patient complicated with interstitial lung abnormality. BMC Pulmonary Medicine. https://doi.org/10.1186/s12890-023-02367-x

Source records